Document is current
Any future updates will be listed below
-
Authors
Simó, Rafael https://orcid.org/0000-0003-0475-3096
Ramos, Hugo https://orcid.org/0000-0001-6443-7576
García-Ramírez, Marta
Hernández, Cristina
-
Funding
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (ICI20/00129)
Ministerio de Ciencia, Innovación y Universidades [Spain]
- License Information
-
More Information
Article History
Received: 23 May 2025
Revised: 19 June 2025
Accepted: 2 July 2025
First Online: 15 July 2025
Competing interests
: Two of the authors (RS and CH) are inventors of the patent PCT/EP2017/060234, which is related to the use of dipeptidyl peptidase-4 inhibitors (sitagliptin) for topical eye treatment of retinal neurodegenerative diseases.
